Items Tagged ‘lung cancer’
November 2, 2021
Unlocking new genetic testing treatment pathways to save time, lives and resources
Genomics experts worldwide released a paper highlighting advances in rare disease, cancer, population health and carrier screening at the 10th Annual Individualizing Medicine Conference on Saturday, Oct. 9. “The use cases we explored in the paper, ‘The Economic Analysis of the Value of Genetic Testing’ are only the tip of the iceberg in the realm of precision medicine,” says co-author Konstantinos […]
Tags: genetic testing, Individualizing Medicine Conference, Konstantinos Lazaridis, liver cancer, lung cancer, population health, precision medicine, rare disease
January 11, 2021
Mayo Clinic Research in the news — 1/11/2021
In the news you’ll find Mayo Clinic research and faculty cited on a variety of topics including women’s health, patient consent, migraine, palliative care and of course COVID-19. Opinion: Preventing Alzheimer’s in Women Requires a Lifespan Approach Being patient, 1/8/2021 Carolee Lee of WHAM! (Women’s Health Access Matters) and Michelle M. Mielke at the Specialized […]
Tags: Alzheimer's disease, Amy Kotsenas, artificial intelligence, Barrett's esophagus, COVID-19, data science, esophageal cancer, Frank Porreca, gene mutation, genetic testing, Hilary DuBrock, lung cancer
December 21, 2020
Mayo Clinic Research in the news — 12/21/2020
Mid-December, many people are focused on activities and information related to the holidays. The news media are no exception, with very little attention paid to health care research, unless it has a holiday hook. As a result, news is slim about various advancements in understanding, treating and preventing disease. Nonetheless, Mayo Clinic Research and researchers […]
Tags: ADHD, antibodies, artificial intelligence, Barrett's esophagus, Brian Lacy, cancer, cardiovascular disease, clinical trials, COVID-19, data science, epidemiology, esophageal cancer
March 4, 2020
Providers investigate less invasive procedures for lung cancer and COPD
By Advancing the Science contributor 
By Sara Nick At Mayo Clinic, research and care often weave together. Many times this results in Mayo patients being the first to benefit from novel options for diagnosis or treatment. For instance, pulmonologists are testing the potential for new, minimally invasive procedures to diagnose and treat conditions including lung cancer and chronic obstructive pulmonary […]
Tags: chronic bronchitis, collaboration, COPD, emphysema, Janani Reisenauer, lung cancer, minimally invasive procedure, pulmonary and critical care medicine, pulmonology, robotic technology, Sebastian Fernandez-Bussy, team science
December 30, 2019
Research highlights from Florida – fruitful in 2019
By Advancing the Science contributor
Florida sunshine doesn’t just contribute to big, juicy oranges. In 2019, Florida was a hotbed of growth for Mayo Clinic Research, with 11.8% more funding leading to new capabilities such as ex vivo perfusion for lungs – leading to more available for transplant, and carbon ion therapy for cancer – currently not available to patients in the U.S. Read on for more on these and other practice transforming activities.
Tags: artificial intelligence, biopsy, breast cancer, cancer, cancer vaccine, carbon ion therapy, Center for Individualized Medicine, clinical trials, ex vivo lung perfusion, immunology, Keith Knutson, lung cancer
September 3, 2019
Research News Roundup–August 2019
Each month, we publish Mayo Clinic’s Research News Roundup. This article includes brief summaries and links to news releases from the preceding month that discuss some of our latest medical research. It also connects readers to related resources. Read on for recent findings of Mayo Clinic Research: Genetically manipulating protein level in colon cancer cells can […]
Tags: Alan Fields, artificial intelligence, atrial fibrillation, basic science, cardiology, cardiovascular disease, chemotherapy, Colin West, colorectal cancer, diabetes, Frank Sinicrope, Lotte Dyrbye
July 25, 2018
Advances in lung cancer immunotherapy and management of immune-mediated adverse events
By Advancing the Science contributor
Over the last few years, immunotherapy using immune checkpoint inhibitors targeting programmed cell death receptor 1 (PD-1) or programmed cell death receptor ligand 1 (PD-L1) has revolutionized the therapeutic approach to advanced-stage non-small cell lung cancer and numerous other malignancies. Monotherapy, using the anti-PD-1 antibody pembrolizumab, is now Food and Drug Administration (FDA) approved for […]
Tags: clinical trials, immunotherapy, lung cancer, Mayo Clinic Cancer Center, measles virus
June 5, 2018
Research News Roundup-May 2018
The Mayo Clinic Research News Roundup includes brief summaries and links to research news releases from the past month. It also connects readers to related resources. Read on for more information from Mayo Clinic Research. News flash about hot flashes: They can last longer than you think Mayo Clinic study finds women are experiencing hot flashes, night […]
Tags: All of Us, atrial fibrillation, Center for Individualized Medicine, Center for the Science of Health Care Delivery, Eva Galanis, Gianrico Farrugia, HLHS, hypoplastic left heart syndrome, Judy Boughey, lung cancer, Matthew Goetz, Mayo Clinic Cancer Center
December 29, 2016
Drug combo stems tumor growth in lung cancer
Researchers on Mayo Clinic’s campus in Jacksonville, Florida, have shut down one of the most common and lethal forms of lung cancer by combining the rheumatoid arthritis drug auranofin with an experimental targeted agent. The combination therapy worked in a laboratory study to stop lung adenocarcinoma associated with mutation of the KRAS gene. The study […]
Tags: chemotherapy, Forefront, lung cancer